<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>20 Localized EsoCa | GI Surgical Oncology</title>
  <meta name="description" content="Orientation Manual for GI Surgical Oncology Service" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="20 Localized EsoCa | GI Surgical Oncology" />
  <meta property="og:type" content="book" />
  
  
  <meta property="og:description" content="Orientation Manual for GI Surgical Oncology Service" />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="20 Localized EsoCa | GI Surgical Oncology" />
  
  <meta name="twitter:description" content="Orientation Manual for GI Surgical Oncology Service" />
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="superficial.html"/>
<link rel="next" href="locally_advanced.html"/>
<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li>GI Surgical Oncology</li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> Overview</a>
<ul>
<li class="chapter" data-level="1.1" data-path="index.html"><a href="index.html#absences"><i class="fa fa-check"></i><b>1.1</b> Absences</a></li>
<li class="chapter" data-level="1.2" data-path="index.html"><a href="index.html#communication"><i class="fa fa-check"></i><b>1.2</b> Communication</a></li>
<li class="chapter" data-level="1.3" data-path="index.html"><a href="index.html#inpatients"><i class="fa fa-check"></i><b>1.3</b> Inpatients</a></li>
<li class="chapter" data-level="1.4" data-path="index.html"><a href="index.html#er-admits"><i class="fa fa-check"></i><b>1.4</b> ER admits</a></li>
<li class="chapter" data-level="1.5" data-path="index.html"><a href="index.html#medical-records"><i class="fa fa-check"></i><b>1.5</b> Medical Records</a></li>
<li class="chapter" data-level="1.6" data-path="index.html"><a href="index.html#operative-logs"><i class="fa fa-check"></i><b>1.6</b> Operative Logs</a></li>
<li class="chapter" data-level="1.7" data-path="index.html"><a href="index.html#case-assignment"><i class="fa fa-check"></i><b>1.7</b> Case Assignment</a></li>
<li class="chapter" data-level="1.8" data-path="index.html"><a href="index.html#clinic"><i class="fa fa-check"></i><b>1.8</b> Clinic</a></li>
<li class="chapter" data-level="1.9" data-path="index.html"><a href="index.html#work-hours"><i class="fa fa-check"></i><b>1.9</b> Work Hours</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="inpatient.html"><a href="inpatient.html"><i class="fa fa-check"></i><b>2</b> Inpatient</a>
<ul>
<li class="chapter" data-level="2.1" data-path="inpatient.html"><a href="inpatient.html#admissions"><i class="fa fa-check"></i><b>2.1</b> Admissions</a></li>
<li class="chapter" data-level="2.2" data-path="inpatient.html"><a href="inpatient.html#rounds"><i class="fa fa-check"></i><b>2.2</b> Rounds</a></li>
<li class="chapter" data-level="2.3" data-path="inpatient.html"><a href="inpatient.html#resident-halo-teams"><i class="fa fa-check"></i><b>2.3</b> Resident Halo teams:</a></li>
<li class="chapter" data-level="2.4" data-path="inpatient.html"><a href="inpatient.html#attending-halo-teams"><i class="fa fa-check"></i><b>2.4</b> Attending Halo teams:</a></li>
<li class="chapter" data-level="2.5" data-path="inpatient.html"><a href="inpatient.html#consults"><i class="fa fa-check"></i><b>2.5</b> Consults</a></li>
<li class="chapter" data-level="2.6" data-path="inpatient.html"><a href="inpatient.html#conferences"><i class="fa fa-check"></i><b>2.6</b> Conferences</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="rounds-1.html"><a href="rounds-1.html"><i class="fa fa-check"></i><b>3</b> Rounds</a></li>
<li class="chapter" data-level="4" data-path="progress-notes.html"><a href="progress-notes.html"><i class="fa fa-check"></i><b>4</b> Progress Notes</a></li>
<li class="chapter" data-level="5" data-path="discharges.html"><a href="discharges.html"><i class="fa fa-check"></i><b>5</b> Discharges</a></li>
<li class="part"><span><b>Postoperative Care</b></span></li>
<li class="chapter" data-level="6" data-path="colectomy---hill.html"><a href="colectomy---hill.html"><i class="fa fa-check"></i><b>6</b> Colectomy - Hill</a></li>
<li class="chapter" data-level="7" data-path="lar-ileostomy.html"><a href="lar-ileostomy.html"><i class="fa fa-check"></i><b>7</b> LAR + Ileostomy</a></li>
<li class="chapter" data-level="8" data-path="abdominoperineal-resection.html"><a href="abdominoperineal-resection.html"><i class="fa fa-check"></i><b>8</b> Abdominoperineal Resection</a></li>
<li class="chapter" data-level="9" data-path="esophagectomy-postop.html"><a href="esophagectomy-postop.html"><i class="fa fa-check"></i><b>9</b> Esophagectomy Postop</a></li>
<li class="chapter" data-level="10" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html"><i class="fa fa-check"></i><b>10</b> Esophagectomy Ward</a>
<ul>
<li class="chapter" data-level="10.1" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#anti-hypertensives"><i class="fa fa-check"></i><b>10.1</b> Anti-Hypertensives</a></li>
<li class="chapter" data-level="10.2" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#chest-tubes"><i class="fa fa-check"></i><b>10.2</b> Chest tubes</a></li>
<li class="chapter" data-level="10.3" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#gi-medicines"><i class="fa fa-check"></i><b>10.3</b> GI Medicines</a></li>
<li class="chapter" data-level="10.4" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#leak_evaluation"><i class="fa fa-check"></i><b>10.4</b> Evaluation for leak</a>
<ul>
<li class="chapter" data-level="10.4.1" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#drain_amylase"><i class="fa fa-check"></i><b>10.4.1</b> Drain Amylase</a></li>
<li class="chapter" data-level="10.4.2" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#ct_esophagram"><i class="fa fa-check"></i><b>10.4.2</b> CT esophagram</a></li>
</ul></li>
<li class="chapter" data-level="10.5" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#anastomotic-leak-treatment"><i class="fa fa-check"></i><b>10.5</b> Anastomotic Leak Treatment</a></li>
<li class="chapter" data-level="10.6" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#jejunostomy_diabetes"><i class="fa fa-check"></i><b>10.6</b> Jejunostomy + Diabetes</a></li>
</ul></li>
<li class="part"><span><b>Hill OR</b></span></li>
<li class="chapter" data-level="11" data-path="colorectal-cases---hill.html"><a href="colorectal-cases---hill.html"><i class="fa fa-check"></i><b>11</b> Colorectal Cases - Hill</a></li>
<li class="chapter" data-level="12" data-path="student-emr-notes-policy.html"><a href="student-emr-notes-policy.html"><i class="fa fa-check"></i><b>12</b> Student EMR Notes Policy</a></li>
<li class="part"><span><b>Salo OR</b></span></li>
<li class="chapter" data-level="13" data-path="cv_port_salo.html"><a href="cv_port_salo.html"><i class="fa fa-check"></i><b>13</b> Central Venous Port (IJ)</a></li>
<li class="chapter" data-level="14" data-path="lap-jejunostomy.html"><a href="lap-jejunostomy.html"><i class="fa fa-check"></i><b>14</b> Lap Jejunostomy</a></li>
<li class="chapter" data-level="15" data-path="lap_gastrostomy_salo.html"><a href="lap_gastrostomy_salo.html"><i class="fa fa-check"></i><b>15</b> Lap Gastrostomy</a></li>
<li class="chapter" data-level="16" data-path="esophagectomy-one-stage.html"><a href="esophagectomy-one-stage.html"><i class="fa fa-check"></i><b>16</b> Esophagectomy One Stage</a></li>
<li class="part"><span><b>Esophageal Cancer</b></span></li>
<li class="chapter" data-level="17" data-path="EsoIntro.html"><a href="EsoIntro.html"><i class="fa fa-check"></i><b>17</b> Esophageal Overview</a></li>
<li class="chapter" data-level="18" data-path="staging.html"><a href="staging.html"><i class="fa fa-check"></i><b>18</b> Staging</a></li>
<li class="chapter" data-level="19" data-path="superficial.html"><a href="superficial.html"><i class="fa fa-check"></i><b>19</b> Superficial EsoCa</a>
<ul>
<li class="chapter" data-level="19.1" data-path="superficial.html"><a href="superficial.html#emr"><i class="fa fa-check"></i><b>19.1</b> Endscopic Mucosal Resection (EMR)</a></li>
</ul></li>
<li class="chapter" data-level="20" data-path="localized.html"><a href="localized.html"><i class="fa fa-check"></i><b>20</b> Localized EsoCa</a>
<ul>
<li class="chapter" data-level="20.1" data-path="localized.html"><a href="localized.html#t1b-tumors"><i class="fa fa-check"></i><b>20.1</b> T1b Tumors</a></li>
<li class="chapter" data-level="20.2" data-path="localized.html"><a href="localized.html#t2n0-tumors"><i class="fa fa-check"></i><b>20.2</b> T2N0 Tumors</a></li>
<li class="chapter" data-level="20.3" data-path="localized.html"><a href="localized.html#staging-of-t2n0-tumors"><i class="fa fa-check"></i><b>20.3</b> Staging of T2N0 Tumors</a></li>
</ul></li>
<li class="chapter" data-level="21" data-path="locally_advanced.html"><a href="locally_advanced.html"><i class="fa fa-check"></i><b>21</b> Locally Advanced EsoCa</a>
<ul>
<li class="chapter" data-level="21.1" data-path="locally_advanced.html"><a href="locally_advanced.html#trimodality"><i class="fa fa-check"></i><b>21.1</b> Trimodality Therapy</a>
<ul>
<li class="chapter" data-level="21.1.1" data-path="locally_advanced.html"><a href="locally_advanced.html#neoadjuvant-chemort-for-scca"><i class="fa fa-check"></i><b>21.1.1</b> Neoadjuvant chemoRT for SCCA</a></li>
<li class="chapter" data-level="21.1.2" data-path="locally_advanced.html"><a href="locally_advanced.html#neoadjuvant-chemotheraphy-followed-by-surgery"><i class="fa fa-check"></i><b>21.1.2</b> Neoadjuvant chemotheraphy followed by surgery</a></li>
</ul></li>
<li class="chapter" data-level="21.2" data-path="locally_advanced.html"><a href="locally_advanced.html#ge-junction"><i class="fa fa-check"></i><b>21.2</b> GE Junction</a></li>
<li class="chapter" data-level="21.3" data-path="locally_advanced.html"><a href="locally_advanced.html#induction-chemotherapy-followed-by-chemort"><i class="fa fa-check"></i><b>21.3</b> Induction chemotherapy followed by chemoRT</a></li>
<li class="chapter" data-level="21.4" data-path="locally_advanced.html"><a href="locally_advanced.html#postoperative-chemoradiation"><i class="fa fa-check"></i><b>21.4</b> Postoperative chemoradiation</a></li>
</ul></li>
<li class="chapter" data-level="22" data-path="eso_dcrt.html"><a href="eso_dcrt.html"><i class="fa fa-check"></i><b>22</b> Chemoradiation</a>
<ul>
<li class="chapter" data-level="22.1" data-path="eso_dcrt.html"><a href="eso_dcrt.html#phase-ii-studies"><i class="fa fa-check"></i><b>22.1</b> Phase II Studies</a></li>
<li class="chapter" data-level="22.2" data-path="eso_dcrt.html"><a href="eso_dcrt.html#chemort-vs-trimodality-therapy"><i class="fa fa-check"></i><b>22.2</b> ChemoRT vs Trimodality therapy</a></li>
</ul></li>
<li class="chapter" data-level="23" data-path="radiation.html"><a href="radiation.html"><i class="fa fa-check"></i><b>23</b> Radiation</a></li>
<li class="chapter" data-level="24" data-path="esophagectomy.html"><a href="esophagectomy.html"><i class="fa fa-check"></i><b>24</b> Esophagectomy</a>
<ul>
<li class="chapter" data-level="24.0.1" data-path="esophagectomy.html"><a href="esophagectomy.html#preoperative-evaluation"><i class="fa fa-check"></i><b>24.0.1</b> Preoperative Evaluation</a></li>
<li class="chapter" data-level="24.1" data-path="esophagectomy.html"><a href="esophagectomy.html#minimally-invasive-esophagectomy"><i class="fa fa-check"></i><b>24.1</b> Minimally-invasive Esophagectomy</a></li>
<li class="chapter" data-level="24.2" data-path="esophagectomy.html"><a href="esophagectomy.html#transthoracic"><i class="fa fa-check"></i><b>24.2</b> Transthoracic</a></li>
<li class="chapter" data-level="24.3" data-path="esophagectomy.html"><a href="esophagectomy.html#transhiatal"><i class="fa fa-check"></i><b>24.3</b> Transhiatal</a></li>
<li class="chapter" data-level="24.4" data-path="esophagectomy.html"><a href="esophagectomy.html#three-hole"><i class="fa fa-check"></i><b>24.4</b> Three-hole</a></li>
<li class="chapter" data-level="24.5" data-path="esophagectomy.html"><a href="esophagectomy.html#extended-lymphadenectomy"><i class="fa fa-check"></i><b>24.5</b> Extended lymphadenectomy</a></li>
<li class="chapter" data-level="24.6" data-path="esophagectomy.html"><a href="esophagectomy.html#salvage-esophagectomy"><i class="fa fa-check"></i><b>24.6</b> Salvage esophagectomy</a></li>
</ul></li>
<li class="chapter" data-level="25" data-path="eso_metastatic.html"><a href="eso_metastatic.html"><i class="fa fa-check"></i><b>25</b> Metastatic EsoCa</a>
<ul>
<li class="chapter" data-level="25.1" data-path="eso_metastatic.html"><a href="eso_metastatic.html#palliative-radiation"><i class="fa fa-check"></i><b>25.1</b> Palliative radiation</a></li>
<li class="chapter" data-level="25.2" data-path="eso_metastatic.html"><a href="eso_metastatic.html#chemoradiation-vs-chemotherapy-in-stage-iv"><i class="fa fa-check"></i><b>25.2</b> Chemoradiation vs chemotherapy in Stage IV</a></li>
<li class="chapter" data-level="25.3" data-path="eso_metastatic.html"><a href="eso_metastatic.html#stents-for-malignant-disease"><i class="fa fa-check"></i><b>25.3</b> Stents for malignant disease</a></li>
</ul></li>
<li class="chapter" data-level="26" data-path="eso_survivorship.html"><a href="eso_survivorship.html"><i class="fa fa-check"></i><b>26</b> Survivorship</a>
<ul>
<li class="chapter" data-level="26.1" data-path="eso_survivorship.html"><a href="eso_survivorship.html#nutritional-consequences"><i class="fa fa-check"></i><b>26.1</b> Nutritional consequences</a></li>
<li class="chapter" data-level="26.2" data-path="eso_survivorship.html"><a href="eso_survivorship.html#cardiac-toxicity-of-radiation"><i class="fa fa-check"></i><b>26.2</b> Cardiac toxicity of radiation</a></li>
<li class="chapter" data-level="26.3" data-path="eso_survivorship.html"><a href="eso_survivorship.html#eso_surveillance"><i class="fa fa-check"></i><b>26.3</b> Surveillance</a></li>
</ul></li>
<li class="part"><span><b>Gastric Cancer</b></span></li>
<li class="chapter" data-level="27" data-path="gastric-overview.html"><a href="gastric-overview.html"><i class="fa fa-check"></i><b>27</b> Gastric Overview</a></li>
<li class="chapter" data-level="28" data-path="gast_superficial.html"><a href="gast_superficial.html"><i class="fa fa-check"></i><b>28</b> Superficial Gastric</a></li>
<li class="chapter" data-level="29" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html"><i class="fa fa-check"></i><b>29</b> Locally-Advanced Gastric</a>
<ul>
<li class="chapter" data-level="29.1" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#preoperative-chemotherapy"><i class="fa fa-check"></i><b>29.1</b> Preoperative Chemotherapy</a></li>
<li class="chapter" data-level="29.2" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#postoperative-chemotherapy"><i class="fa fa-check"></i><b>29.2</b> Postoperative chemotherapy</a></li>
<li class="chapter" data-level="29.3" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#postoperative-chemoradiation-1"><i class="fa fa-check"></i><b>29.3</b> Postoperative chemoradiation</a></li>
<li class="chapter" data-level="29.4" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#preoperative-chemoradiation"><i class="fa fa-check"></i><b>29.4</b> Preoperative chemoradiation</a></li>
</ul></li>
<li class="part"><span><b>Colon Cancer</b></span></li>
<li class="chapter" data-level="30" data-path="colectomy.html"><a href="colectomy.html"><i class="fa fa-check"></i><b>30</b> Colectomy</a>
<ul>
<li class="chapter" data-level="30.1" data-path="colectomy.html"><a href="colectomy.html#extended-node-dissection"><i class="fa fa-check"></i><b>30.1</b> Extended Node dissection</a></li>
</ul></li>
<li class="chapter" data-level="31" data-path="chemotherapy.html"><a href="chemotherapy.html"><i class="fa fa-check"></i><b>31</b> Chemotherapy</a>
<ul>
<li class="chapter" data-level="31.1" data-path="chemotherapy.html"><a href="chemotherapy.html#neoadjuvant-chemotherapy"><i class="fa fa-check"></i><b>31.1</b> Neoadjuvant Chemotherapy</a></li>
</ul></li>
<li class="part"><span><b>Sarcoma</b></span></li>
<li class="chapter" data-level="32" data-path="retroperitoneal.html"><a href="retroperitoneal.html"><i class="fa fa-check"></i><b>32</b> Retroperitoneal</a></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="mailto:jonathan.salo@atriumhealth.org">Feedback and Updates</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">GI Surgical Oncology</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="localized" class="section level1" number="20">
<h1><span class="header-section-number">20</span> Localized EsoCa</h1>
<div id="t1b-tumors" class="section level2" number="20.1">
<h2><span class="header-section-number">20.1</span> T1b Tumors</h2>
</div>
<div id="t2n0-tumors" class="section level2" number="20.2">
<h2><span class="header-section-number">20.2</span> T2N0 Tumors</h2>
<p>Multiple studies have failed to show the additional benefit of chemotherapy or chemoradiation for pT2N0M0 esophageal cancer patients treated with radiation.</p>
<p>Neoadjuvant chemo not likey to be helpful for early stage disease - FFCD 9901 [Mariette 2416] enrolled patients with T1-2 or T3N0 tumors to chemoradiation followed by surgery versus surgery alone. The majority of the tumors (72%) were squamous cell carcinoma.Postoperative mortality was significaly increased in the chemoradiation arm (11.1% vs 3.4%).</p>
<p>Meta-analysis of 5265 patients in 10 studies showed that while neoadjuvant therapy was associated with a reduction in positive margin rate, there was no difference in terms of recurrence or survival.[MOta 176]</p>
<p>French trial FREGAT<span class="citation">(<a href="#ref-markar59" role="doc-biblioref">Markar et al. 2016</a>)</span></p>
<p>Retrospective review of the National Cancer DataBase failed to demonstrate a difference in survival of cT2N0M0 esophageal cancer with or without preoperative chemoradiation.<span class="citation">(<a href="#ref-speicher1195" role="doc-biblioref">Speicher et al. 2014</a>)</span></p>
<p>A retrospective report from Johns Hopkins examined outcomes of T2N0 squamous cell carcinoma patients and showed equivalent outcomes for primary surgery vs neoadjuvant chemoradiation followed by surgery <span class="citation">(<a href="#ref-zhang429" role="doc-biblioref">Zhang et al. 2012</a>)</span></p>
</div>
<div id="staging-of-t2n0-tumors" class="section level2" number="20.3">
<h2><span class="header-section-number">20.3</span> Staging of T2N0 Tumors</h2>
<p>The challenge for treatment decision-making is the limited sensitivity of endoscopic ultrasound in ruling out pT3 or pN+ disease. In other words, if a patient who is thought to have cT2N0 disease undergoes resection, and is found on pathology to have pT3 or pN<sup>+</sup> disease, this would dictate the need for postoperative chemoradiation. In general, chemoradiation after esophagectomy is difficult for patients to tolerate, with a ___ % chance of failure to complete therapy.</p>
<p>Data from the Cleveland Clinic looked at 53 patients judged to be T2N0 by endoscopic ultrasound (uT2N0) were treated with primary surgery. Pathologic examination showed that 17 (37%) were understaged by endoscopic ultrasound, and were pathologic (pT3) in 4 or node positive (pN<sup>+</sup>) in 13 cases. These patients were treated with postoperative adjuvant chemoradiation.<span class="citation">(<a href="#ref-rice317" role="doc-biblioref">Rice et al. 2007</a>)</span></p>
<p>It is critical, therefore, in patients for whom primary surgery is contemplated, to attempt to identify those with occult T3 or N+ disease.</p>
<p>Patients who appear to have limited stage disease benefit from evaluation with a combination of</p>
<p>See also <a href="PMID:25047477" class="uri">PMID:25047477</a></p>
<p>(MTV)</p>
<p>(Tumor Length)</p>
<p>(dysphagia)</p>
<p>##Primary Surgery {#primary_surgery}</p>
<p>NCCN recommends PET scanS</p>
<p>Most common sites of metastasis are liver, lung, bones, adrenal.</p>
<p>PET detects occult metastasis in 10-20% of cases <span class="citation"><a href="#ref-kim403" role="doc-biblioref">Kim et al.</a> (<a href="#ref-kim403" role="doc-biblioref">2009</a>)</span>. Among 129 patients with esophageal cancer, PET detected additional sites of disease in 41% and changed management in 38% <span class="citation">(<a href="#ref-chatterton354" role="doc-biblioref">Chatterton et al. 2009</a>)</span></p>
<p>PET for restaging detects interval development of metastatic disease in 8-17% of cases <span class="citation">(<a href="#ref-vanvliet547" role="doc-biblioref">Vliet et al. 2008</a>)</span></p>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-chatterton354" class="csl-entry">
Chatterton, B. E., I. Ho Shon, A. Baldey, N. Lenzo, A. Patrikeos, B. Kelley, D. Wong, J. E. Ramshaw, and A. M. Scott. 2009. <span>“Positron Emission Tomography Changes Management and Prognostic Stratification in Patients with Oesophageal Cancer: Results of a Multicentre Prospective Study.”</span> <em>Eur J Nucl Med Mol Imaging</em> 36 (3): 354–61. <a href="https://doi.org/10.1007/s00259-008-0959-y">https://doi.org/10.1007/s00259-008-0959-y</a>.
</div>
<div id="ref-kim403" class="csl-entry">
Kim, Tae Jung, Hyae Young Kim, Kyung Won Lee, and Moon Soo Kim. 2009. <span>“Multimodality Assessment of Esophageal Cancer: Preoperative Staging and Monitoring of Response to Therapy.”</span> <em>Radiographics</em> 29 (2): 403–21. <a href="https://doi.org/10.1148/rg.292085106">https://doi.org/10.1148/rg.292085106</a>.
</div>
<div id="ref-markar59" class="csl-entry">
Markar, Sheraz R., Caroline Gronnier, Arnaud Pasquer, Alain Duhamel, Hélène Beal, Jérémie Théreaux, Johan Gagnière, et al. 2016. <span>“Role of Neoadjuvant Treatment in Clinical <span>T2n0m0</span> Oesophageal Cancer: Results from a Retrospective Multi-Center <span>European</span> Study.”</span> <em>Eur J Cancer</em> 56 (March): 59–68. <a href="https://doi.org/10.1016/j.ejca.2015.11.024">https://doi.org/10.1016/j.ejca.2015.11.024</a>.
</div>
<div id="ref-rice317" class="csl-entry">
Rice, T. W., D. P. Mason, S. C. Murthy, Jr. Zuccaro G., D. J. Adelstein, L. A. Rybicki, and E. H. Blackstone. 2007. <span>“<span>T2n0m0</span> Esophageal Cancer.”</span> <em>J Thorac Cardiovasc Surg</em> 133 (2): 317–24. <a href="https://doi.org/10.1016/j.jtcvs.2006.09.023">https://doi.org/10.1016/j.jtcvs.2006.09.023</a>.
</div>
<div id="ref-speicher1195" class="csl-entry">
Speicher, Paul J., Asvin M. Ganapathi, Brian R. Englum, Matthew G. Hartwig, Mark W. Onaitis, Thomas A. D’Amico, and Mark F. Berry. 2014. <span>“Induction Therapy Does Not Improve Survival for Clinical Stage <span>T2n0</span> Esophageal Cancer.”</span> <em>J Thorac Oncol</em> 9 (8): 1195–1201. <a href="https://doi.org/10.1097/JTO.0000000000000228">https://doi.org/10.1097/JTO.0000000000000228</a>.
</div>
<div id="ref-vanvliet547" class="csl-entry">
Vliet, E. P. M. van, M. H. Heijenbrok-Kal, M. G. M. Hunink, E. J. Kuipers, and P. D. Siersema. 2008. <span>“Staging Investigations for Oesophageal Cancer: A Meta-Analysis.”</span> <em>Br J Cancer</em> 98 (3): 547–57. <a href="https://doi.org/10.1038/sj.bjc.6604200">https://doi.org/10.1038/sj.bjc.6604200</a>.
</div>
<div id="ref-zhang429" class="csl-entry">
Zhang, J. Q., C. M. Hooker, M. V. Brock, J. Shin, S. Lee, R. How, N. Franco, H. Prevas, A. Hulbert, and S. C. Yang. 2012. <span>“Neoadjuvant Chemoradiation Therapy Is Beneficial for Clinical Stage <span>T2</span> <span>N0</span> Esophageal Cancer Patients Due to Inaccurate Preoperative Staging.”</span> <em>Ann Thorac Surg</em> 93 (2): 429-35; discussion 436-7. <a href="https://doi.org/10.1016/j.athoracsur.2011.10.061">https://doi.org/10.1016/j.athoracsur.2011.10.061</a>.
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="superficial.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="locally_advanced.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/jcsalo/gi_surgonc/edit/main/535-eso_t2.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["gi_surgonc.pdf", "gi_surgonc.epub"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true,
"search": true,
"sharing": false
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
